Case of success · Ceva · Canine MMVD Cardalis

Ceva Cardalis

simulated clinical scenarios

Case summary

Interactive infographic for veterinarians with 3D visualization of organs, clinical scenarios, and ACVIM classification regarding canine mitral valve disease and its treatment

CEVA Santé Animale is one of the three veterinary pharmaceutical companies with the highest growth worldwide, present in more than 110 countries. In the canine cardiology field, the degenerative disease of the mitral valve (MMVD) is the most frequent acquired heart disease in small dogs of advanced age, and its diagnosis, classification, and treatment require the veterinarian to combine anatomical knowledge, clinical judgment, and constant updating with recognized veterinary guidelines. To support the professional in this process, CEVA has developed, together with Imascono Health, an interactive infographic that brings together all the clinical knowledge about MMVD and its treatment with Cardalis in a single application.

Client

Ceva · Canine MMVD Cardalis

Sector

Healthcare

Service

3D Anatomical Models · Digital Twins

simulated clinical scenarios

110

countries where Ceva operates

2012

European launch of Cardalis

Facing a similar healthcare challenge?

Tell us about it. In under 24 hours we tell you what results you could expect in your company.

Tell us your challenge →

01 The challenge

Translating a complex clinical consensus into an everyday tool

Mitral valve degenerative disease is the most common acquired heart disease in small dogs of advanced age, with a delicate clinical progression, associated cardiac and pulmonary complications, and a therapeutic decision that must be adjusted according to the individual patient's condition. The ACVIM international clinical criteria and recognized veterinary guidelines provide the framework, but their consultation in the daily practice of veterinarians is slow and scattered among specialized literature, protocols, and technical sheets. CEVA sought a digital tool that would bring together all advanced clinical knowledge in a visual and intuitive format, capable of assisting the professional in diagnosis, classification, and therapeutic decision-making.

02 The solution

The canine heart, explorable and interactive

The solution is a multidisciplinary digital application specialized in canine mitral valve degenerative disease, developed by Imascono Health for CEVA. The tool allows the veterinarian to visualize in 3D the different organs of the patient and their relationship with the pathology, access interactive infographics, scientific literature and specific clinical content, and integrate the diagnosis of mitral valve disease with its classification according to the ACVIM criteria. The professional can simulate four clinical scenarios with different levels of severity, observe possible cardiac and pulmonary reactions, understand key processes such as the activation of the RAAS system and anticipate symptoms before they appear, adjusting treatment in a personalized way and integrating the information associated with Cardalis in each therapeutic decision.

Next step

We developed 4 complex scenarios in its pilot programme. What could we achieve working with your company?

Request a diagnosis →

Key learnings

What this case teaches the sector.

The veterinarian no longer consults the literature, they explore it

Today's clinical professional doesn't have the time that traditional literature searches require. When the recognised veterinary guidelines, the ACVIM classification and the scientific evidence are integrated into a visual, interactive tool, looking things up stops being an obstacle and becomes part of the clinical workflow itself.

A drug is only as good as the decision that goes with it

In canine cardiology, choosing the appropriate treatment depends not only on the efficacy of the drug but also on the clinical judgment of the prescribing veterinarian. Providing the veterinarian with a tool that integrates knowledge about the disease and about Cardalis multiplies the therapeutic value of the product: it informs the decision, not just implements it.

Seeing the organ in 3D anticipates the symptom in the patient

Understanding the progression of a heart disease visually and observing its possible cardiac and pulmonary reactions in an interactive 3D model allows the veterinarian to anticipate the symptoms before they manifest in the patient. Clinical anticipation no longer becomes an accumulated experience but becomes accessible knowledge.

Clinical material is also part of the pharmaceutical company's value proposition

The big veterinary pharmaceutical companies compete on molecular efficacy and price. In recent years, the quality of the clinical material and the digital tools that accompany the product has become a real competitive differentiator: veterinarians prefer to work with the brands that help them decide better.

Let's talk From challenge to product. Tell us yours.

You tell us the challenge; we tell you how we would make it real. We reply in under 24 hours with a first round of feedback. No strings attached.